<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>4 Medizinische Fakultät</title>
<link href="http://hdl.handle.net/10900/33644" rel="alternate"/>
<subtitle/>
<id>http://hdl.handle.net/10900/33644</id>
<updated>2026-09-18T04:24:59Z</updated>
<dc:date>2026-09-18T04:24:59Z</dc:date>
<entry>
<title>Development and validation of the dysarthria impact scale: a patient-reported outcome for motor speech disorders</title>
<link href="http://hdl.handle.net/10900/183337" rel="alternate"/>
<author>
<name>Vogel, Adam P.</name>
</author>
<author>
<name>Synofzik, Matthis</name>
</author>
<author>
<name>Graf, Lisa Helene</name>
</author>
<author>
<name>Weiß, Merit</name>
</author>
<id>http://hdl.handle.net/10900/183337</id>
<updated>2026-09-15T23:01:31Z</updated>
<published>2026-01-01T00:00:00Z</published>
<summary type="text">Development and validation of the dysarthria impact scale: a patient-reported outcome for motor speech disorders
Vogel, Adam P.; Synofzik, Matthis; Graf, Lisa Helene; Weiß, Merit
</summary>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Antineuronal antibody titres in autoimmune encephalitis: clinical implications for diagnosis and long-term immunotherapy</title>
<link href="http://hdl.handle.net/10900/183336" rel="alternate"/>
<author>
<name>Schwab, Hanna</name>
</author>
<author>
<name>Kegele, Josua</name>
</author>
<author>
<name>Lerche, Holger</name>
</author>
<author>
<name>Lauxmann, Stephan</name>
</author>
<author>
<name>Kowarik, Markus</name>
</author>
<id>http://hdl.handle.net/10900/183336</id>
<updated>2026-09-15T23:01:11Z</updated>
<published>2026-01-01T00:00:00Z</published>
<summary type="text">Antineuronal antibody titres in autoimmune encephalitis: clinical implications for diagnosis and long-term immunotherapy
Schwab, Hanna; Kegele, Josua; Lerche, Holger; Lauxmann, Stephan; Kowarik, Markus
</summary>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Integrative preclinical strategy for pharmacokinetic profiling and candidate selection of 3-hydroxypropanamidines: a promising antimalarial class</title>
<link href="http://hdl.handle.net/10900/183335" rel="alternate"/>
<author>
<name>Held, Jana</name>
</author>
<id>http://hdl.handle.net/10900/183335</id>
<updated>2026-09-15T23:01:10Z</updated>
<published>2026-01-01T00:00:00Z</published>
<summary type="text">Integrative preclinical strategy for pharmacokinetic profiling and candidate selection of 3-hydroxypropanamidines: a promising antimalarial class
Held, Jana
</summary>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Prognostic factors for lymph node infestation, long-term survival and recurrence rates in patients with vaginal cancer: a population-based study in Germany</title>
<link href="http://hdl.handle.net/10900/183334" rel="alternate"/>
<author>
<name>Walter, Christina</name>
</author>
<id>http://hdl.handle.net/10900/183334</id>
<updated>2026-09-15T23:01:47Z</updated>
<published>2026-01-01T00:00:00Z</published>
<summary type="text">Prognostic factors for lymph node infestation, long-term survival and recurrence rates in patients with vaginal cancer: a population-based study in Germany
Walter, Christina
</summary>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</entry>
</feed>
